HEPATOAID Trademark

Trademark Overview

On Monday, October 22, 2018, a trademark application was filed for HEPATOAID with the United States Patent and Trademark Office. The USPTO has given the HEPATOAID trademark a serial number of 88164388. The federal status of this trademark filing is REGISTERED as of Tuesday, April 7, 2020. This trademark is owned by Chemi Nutra, LLC. The HEPATOAID trademark is filed in the Chemical Products category with the following description:

Phospholipids used in the manufacture of food products and dietary nutritional food supplements
hepatoaid

General Information

Serial Number88164388
Word MarkHEPATOAID
Filing DateMonday, October 22, 2018
Status700 - REGISTERED
Status DateTuesday, April 7, 2020
Registration Number6030127
Registration DateTuesday, April 7, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2019

Trademark Statements

Goods and ServicesPhospholipids used in the manufacture of food products and dietary nutritional food supplements

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, November 2, 2018
Primary Code001
First Use Anywhere DateThursday, May 30, 2019
First Use In Commerce DateThursday, May 30, 2019

Trademark Owner History

Party NameChemi Nutra, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAustin, TX 78758
Party NameChemi Nutra, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAustin, TX 78758
Party NameChemi Nutra, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAustin, TX 78758

Trademark Events

Event DateEvent Description
Tuesday, April 7, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, February 29, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, February 28, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 13, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 12, 2020ASSIGNED TO LIE
Thursday, February 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 17, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 17, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, December 15, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 15, 2019NON-FINAL ACTION E-MAILED
Sunday, December 15, 2019SU - NON-FINAL ACTION - WRITTEN
Sunday, December 1, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 21, 2019USE AMENDMENT FILED
Sunday, December 1, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 21, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, May 21, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 15, 2019ASSIGNED TO LIE
Monday, February 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 4, 2019EXAMINER'S AMENDMENT ENTERED
Monday, February 4, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 4, 2019EXAMINERS AMENDMENT E-MAILED
Monday, February 4, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 30, 2019ASSIGNED TO EXAMINER
Friday, November 2, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 25, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

hepatoaid food nutritional supplements dietary products manufacture phospholipids used